Scotland Unveils £21m Fund for Rare Diseases

A £21 million fund will been made available to pay for rare orphan drugs that are not currently recommended by the Scotland’s regulatory watchdog, the Scottish Medicines Consortium (SMC). The fund will launch in March, and run until April 2014.  It will help cover successful new Individual Patient Treatment Requests for drugs that target rare

Continue Reading

Ulcerative Colitis Drug Market to Reach $3.7 Billion by 2021

Sales of medication to treat ulcerative colitis in seven key markets are expected to double over the next decade, reaching $3.7 billion by 2021, according new research. The rapid growth will be largely driven by two premium-priced tumour necrosis factor-alpha (TNF-alpha) inhibitors – Abbott/Eisai’s Humira and Janssen/Merck/Mitsubishi Tanabe’s Simponi – and two novel therapies –

Continue Reading

Patient Support Programmes Create Better Result

Patient support programmes (PSP) which involve patients paying part of the fee for their prescription drugs, provide better outcomes than programmes that allow patients to obtain their medication entirely free, eyeforpharma’s Patient Summit conference heard. Patient support programmes offer some monetary support, plus nursing support, and requires patients to pay some additional drug costs to

Continue Reading

Essential Drugs Unavailable as Greek Pharmacists Strike

Approximately 163 critical drugs are now unobtainable from pharmacies in Greece, sector leaders stated, in advance of the country’s pharmacists’ planned one-day strike today. Drugstores in Greece are closed today as owners demonstrate against the fact that social security funds are yet to pay their growing unpaid medication bill. Pharmacists have decided to shut their

Continue Reading

Auranofin ‘Promising’ to Treat Amoebic Dysentery

Auranofin, a common and cheap drug currently used for arthritis, could help fight against parasitic organisms responsible for amoebic dysentery, according to US researchers. Amoebic dysentery is caused by Entamoeba histolytica, which infects the bowels.  It results in severe diarrhoea as well as bloody stools.  More than 70,000 people globally are believed to die from

Continue Reading

MHRA Reveals New Strategy to Crack Down on Fake Drugs

The MHRA (Medicines and Healthcare products Regulatory Agency), a government agency responsible for ensuring that medicines and medical devices work and are acceptably safe, has revealed their new anti-counterfeiting policy to increase the clamp down on fake drugs arriving in the UK supply chain. Developing on the achievements of the initial action plan, the new

Continue Reading

GlaxoSmithKline Announce Q1 Results

Pharmaceutical drug maker, GlaxoSmithKline (GSK), today announced that their revenue increased just 1% in the first quarter, reflecting burdens on the organisation from government price cuts in Europe and some emerging markets, and hard year-by-year comparisons. GSK’s results were boosted by the sale of U.S. rights to a bladder drug, which added approximately £170 million

Continue Reading